Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 12.67% is 36% below its 5-year average of 19.66%, near the low end of its 5-year range (10.56%–26.80%).
As of the fiscal period ended Tuesday, March 31, 2026. 18.57% below its 12-month average of 15.56%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
12.67%
EBITDA MARGIN AVG TTM
15.56%
EBITDA MARGIN AVG 3Y
17.89%
EBITDA MARGIN AVG 5Y
19.66%
EBITDA MARGIN AVG 10Y
17.21%
EBITDA MARGIN AVG 15Y
17.21%
EBITDA MARGIN AVG 20Y
17.09%
CURRENT VS TTM AVG
-18.57%
CURRENT VS 3Y AVG
-29.19%
CURRENT VS 5Y AVG
-35.56%
CURRENT VS 10Y AVG
-26.42%
CURRENT VS 15Y AVG
-26.41%
CURRENT VS 20Y AVG
-25.89%
Bio-Rad Laboratories, Inc.
Market Cap
$8.80B
EBITDA Margin
12.67%
TTM Avg
15.56%
3Y Avg
17.89%
5Y Avg
19.66%
Market Cap
$8.09B
EBITDA Margin
-3.14%
TTM Avg
-1.08%
3Y Avg
-5.02%
5Y Avg
-19.32%
Market Cap
$7.69B
EBITDA Margin
-18.44%
TTM Avg
-56.37%
3Y Avg
-54.16%
5Y Avg
-65.42%
Market Cap
$10.20B
EBITDA Margin
15.05%
TTM Avg
14.69%
3Y Avg
13.35%
5Y Avg
14.10%
Market Cap
$10.21B
EBITDA Margin
2.15%
TTM Avg
3.41%
3Y Avg
4.20%
5Y Avg
4.49%
Market Cap
$10.37B
EBITDA Margin
-7.87%
TTM Avg
-5.60%
3Y Avg
-1.35%
5Y Avg
0.44%
Market Cap
$11.20B
EBITDA Margin
22.69%
TTM Avg
18.62%
3Y Avg
20.95%
5Y Avg
21.80%
Market Cap
$11.29B
EBITDA Margin
17.40%
TTM Avg
22.43%
3Y Avg
29.14%
5Y Avg
30.66%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | $8.80B | 12.67% | 15.56% | 17.89% | 19.66% |
| Oscar Health, Inc. (OSCR)vs › | $8.09B | -3.14% | -1.08% | -5.02% | -19.32% |
| Henry Schein, Inc. (HSIC)vs › | $9.77B | 8.11% | 8.11% | 8.28% | 8.19% |
| Tempus AI, Inc. (TEM)vs › | $7.69B | -18.44% | -56.37% | -54.16% | -65.42% |
| Universal Health Services, Inc. (UHS)vs › | $10.20B | 15.05% | 14.69% | 13.35% | 14.10% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | 2.15% | 3.41% | 4.20% | 4.49% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -7.87% | -5.60% | -1.35% | 0.44% |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.20B | 22.69% | 18.62% | 20.95% | 21.80% |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 17.40% | 22.43% | 29.14% | 30.66% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.19B | 6.82% | 6.08% | -0.44% | -8.67% |
Gross Margin
51.9%
EBITDA Margin
12.7%
Operating Margin
9.3%
Net Margin
6.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | 12.67% |
| 2025-12-31 | 16.49% |
| 2025-09-30 | 18.47% |
| 2025-06-30 | 19.60% |
| 2025-03-31 | 10.56% |
| 2024-12-31 | 16.12% |
| 2024-09-30 | 17.48% |
| 2024-06-30 | 23.20% |
| 2024-03-31 | 16.34% |
| 2023-12-31 | 22.14% |
| 2023-09-30 | 22.00% |
| 2023-06-30 | 21.61% |
| 2023-03-31 | 15.88% |
| 2022-12-31 | 23.11% |
| 2022-09-30 | 18.67% |
| 2022-06-30 | 23.56% |
| 2022-03-31 | 25.68% |
| 2021-12-31 | 19.20% |
| 2021-09-30 | 26.80% |
| 2021-06-30 | 23.51% |
| 2021-03-31 | 19.73% |
| 2020-12-31 | 26.77% |
| 2020-09-30 | 22.12% |
| 2020-06-30 | 16.10% |
| 2020-03-31 | 18.89% |
| 2019-12-31 | 10.02% |
| 2019-09-30 | 18.27% |
| 2019-06-30 | 17.35% |
| 2019-03-31 | 17.97% |
| 2018-12-31 | -32.03% |
| 2018-09-30 | 13.05% |
| 2018-06-30 | 13.56% |
| 2018-03-31 | 14.14% |
| 2017-12-31 | 14.46% |
| 2017-09-30 | 15.28% |
| 2017-06-30 | 6.87% |
| 2017-03-31 | 11.84% |
| 2016-12-31 | 1.68% |
| 2016-09-30 | 13.09% |
| 2016-06-30 | 11.63% |
| 2016-03-31 | 12.69% |
| 2015-12-31 | 16.36% |
| 2015-09-30 | 14.09% |
| 2015-06-30 | 14.29% |
| 2015-03-31 | 14.09% |
| 2014-12-31 | 15.10% |
| 2014-09-30 | 13.26% |
| 2014-06-30 | 15.28% |
| 2014-03-31 | 11.22% |
| 2013-12-31 | 15.65% |
| 2013-09-30 | 13.07% |
| 2013-06-30 | 16.46% |
| 2013-03-31 | 13.38% |
| 2012-12-31 | 18.78% |
| 2012-09-30 | 19.32% |
| 2012-06-30 | 20.56% |
| 2012-03-31 | 17.57% |
| 2011-12-31 | 21.59% |
| 2011-09-30 | 20.19% |
| 2011-06-30 | 18.75% |
| 2011-03-31 | 19.63% |
| 2010-12-31 | 20.00% |
| 2010-09-30 | 21.45% |
| 2010-06-30 | 20.16% |
| 2010-03-31 | 19.99% |
| 2009-12-31 | 11.37% |
| 2009-09-30 | 20.30% |
| 2009-06-30 | 19.04% |
| 2009-03-31 | 18.40% |
| 2008-12-31 | 10.06% |
| 2008-09-30 | 17.24% |
| 2008-06-30 | 18.85% |
| 2008-03-31 | 17.40% |
| 2007-12-31 | 10.23% |
| 2007-09-30 | 15.33% |
| 2007-06-30 | 14.79% |
| 2007-03-31 | 16.50% |
| 2006-12-31 | 11.88% |
| 2006-09-30 | 14.34% |
| 2006-06-30 | 17.84% |
| 2006-03-31 | 19.57% |
| 2005-12-31 | 12.47% |
| 2005-09-30 | 14.08% |
| 2005-06-30 | 14.71% |
| 2005-03-31 | 18.47% |
| 2004-12-31 | 14.65% |
| 2004-09-30 | 10.11% |
| 2004-06-30 | 17.77% |
| 2004-03-31 | 17.50% |
| 2003-12-31 | 16.72% |
| 2003-09-30 | 17.74% |
| 2003-06-30 | 18.58% |
| 2003-03-31 | 21.98% |
| 2002-12-31 | 18.10% |
| 2002-09-30 | 20.33% |
| 2002-06-30 | 19.34% |
